Transcript ImpediMed Limited, Q2 2023 Earnings Call, Jan 30, 2023 - Marketscreener.com
About 67% of Amer Renal's investor base is looking to short. The analysis of current outlook of investing in Amer Renal Assoc suggests that many traders are alarmed regarding Amer Renal's prospects. The current market sentiment, together with Amer Renal's historical and current headlines, can help investors time the market. In addition, many technical investors use Amer Renal Assoc stock news signals to limit their universe of possible portfolio assets.
Amer |
Transcript ImpediMed Limited, Q2 2023 Earnings Call, Jan 30, 2023 Marketscreener.com
Read at news.google.com
 |
Amer Renal Fundamental Analysis
We analyze Amer Renal's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amer Renal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amer Renal based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Amer Renal is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Amer Renal Assoc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amer Renal stock to make a market-neutral strategy. Peer analysis of Amer Renal could also be used in its relative valuation, which is a method of valuing Amer Renal by comparing valuation metrics with similar companies.
Peers
Amer Renal Related Equities
| RAY | Raytech Holding | 5.92 | ||||
| ACU | Acme United | 3.82 | ||||
| MTEX | Mannatech Incorporated | 3.74 | ||||
| WEYS | Weyco | 0.50 | ||||
| SFL | SFL | 1.15 | ||||
| IPAR | Inter Parfums | 1.17 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Amer Stock
If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |